S&P 500   2,598.76 (-1.06%)
DOW   22,113.62 (-0.96%)
QQQ   191.60 (-0.23%)
AAPL   255.67 (+0.33%)
FB   168.06 (+1.27%)
MSFT   160.14 (-0.06%)
GOOGL   1,162.06 (+1.37%)
AMZN   1,973.01 (+0.46%)
CGC   14.52 (+0.35%)
NVDA   262.53 (-1.07%)
BABA   193.97 (+1.41%)
MU   42.96 (-3.48%)
GE   7.97 (+1.27%)
TSLA   525.13 (+4.58%)
AMD   46.33 (-3.20%)
T   29.39 (-2.78%)
ACB   0.91 (+2.24%)
F   4.82 (-4.18%)
NFLX   373.60 (+0.71%)
GILD   74.44 (-1.98%)
DIS   97.65 (-1.95%)
S&P 500   2,598.76 (-1.06%)
DOW   22,113.62 (-0.96%)
QQQ   191.60 (-0.23%)
AAPL   255.67 (+0.33%)
FB   168.06 (+1.27%)
MSFT   160.14 (-0.06%)
GOOGL   1,162.06 (+1.37%)
AMZN   1,973.01 (+0.46%)
CGC   14.52 (+0.35%)
NVDA   262.53 (-1.07%)
BABA   193.97 (+1.41%)
MU   42.96 (-3.48%)
GE   7.97 (+1.27%)
TSLA   525.13 (+4.58%)
AMD   46.33 (-3.20%)
T   29.39 (-2.78%)
ACB   0.91 (+2.24%)
F   4.82 (-4.18%)
NFLX   373.60 (+0.71%)
GILD   74.44 (-1.98%)
DIS   97.65 (-1.95%)
S&P 500   2,598.76 (-1.06%)
DOW   22,113.62 (-0.96%)
QQQ   191.60 (-0.23%)
AAPL   255.67 (+0.33%)
FB   168.06 (+1.27%)
MSFT   160.14 (-0.06%)
GOOGL   1,162.06 (+1.37%)
AMZN   1,973.01 (+0.46%)
CGC   14.52 (+0.35%)
NVDA   262.53 (-1.07%)
BABA   193.97 (+1.41%)
MU   42.96 (-3.48%)
GE   7.97 (+1.27%)
TSLA   525.13 (+4.58%)
AMD   46.33 (-3.20%)
T   29.39 (-2.78%)
ACB   0.91 (+2.24%)
F   4.82 (-4.18%)
NFLX   373.60 (+0.71%)
GILD   74.44 (-1.98%)
DIS   97.65 (-1.95%)
S&P 500   2,598.76 (-1.06%)
DOW   22,113.62 (-0.96%)
QQQ   191.60 (-0.23%)
AAPL   255.67 (+0.33%)
FB   168.06 (+1.27%)
MSFT   160.14 (-0.06%)
GOOGL   1,162.06 (+1.37%)
AMZN   1,973.01 (+0.46%)
CGC   14.52 (+0.35%)
NVDA   262.53 (-1.07%)
BABA   193.97 (+1.41%)
MU   42.96 (-3.48%)
GE   7.97 (+1.27%)
TSLA   525.13 (+4.58%)
AMD   46.33 (-3.20%)
T   29.39 (-2.78%)
ACB   0.91 (+2.24%)
F   4.82 (-4.18%)
NFLX   373.60 (+0.71%)
GILD   74.44 (-1.98%)
DIS   97.65 (-1.95%)
Log in

NASDAQ:MASI - Masimo Stock Price, Forecast & News

$175.70
-4.06 (-2.26 %)
(As of 03/31/2020 03:13 PM ET)
Today's Range
$174.30
Now: $175.70
$180.45
50-Day Range
$148.38
MA: $174.40
$186.78
52-Week Range
$118.93
Now: $175.70
$187.85
Volume18,993 shs
Average Volume653,359 shs
Market Capitalization$9.37 billion
P/E Ratio51.08
Dividend YieldN/A
Beta1.04
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. Additionally, the company offers Trace, a patient data visualization and reporting software that monitors Masimo Root and Radical-7. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, long term care facilities, veterinarians and consumers. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.
Read More
Masimo logo

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:MASI
CUSIP57479510
Phone949-297-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$937.84 million
Cash Flow$3.82 per share
Book Value$21.90 per share

Profitability

Net Income$196.22 million

Miscellaneous

Employees1,600
Market Cap$9.37 billion
Next Earnings Date5/4/2020 (Estimated)
OptionableOptionable

Receive MASI News and Ratings via Email

Sign-up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter.


Masimo (NASDAQ:MASI) Frequently Asked Questions

How has Masimo's stock been impacted by COVID-19 (Coronavirus)?

Masimo's stock was trading at $182.64 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MASI shares have decreased by 3.5% and is now trading at $176.27. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Masimo?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Masimo.

When is Masimo's next earnings date?

Masimo is scheduled to release its next quarterly earnings announcement on Monday, May 4th 2020. View our earnings forecast for Masimo.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) announced its quarterly earnings results on Wednesday, February, 19th. The medical equipment provider reported $0.91 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.87 by $0.04. The medical equipment provider earned $247.51 million during the quarter, compared to analysts' expectations of $243.79 million. Masimo had a return on equity of 17.03% and a net margin of 20.92%. The company's quarterly revenue was up 10.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.83 earnings per share. View Masimo's earnings history.

What guidance has Masimo issued on next quarter's earnings?

Masimo updated its FY20 earnings guidance on Wednesday, February, 19th. The company provided earnings per share guidance of $3.56 for the period, compared to the Thomson Reuters consensus estimate of $3.56. The company issued revenue guidance of $1035 million, compared to the consensus revenue estimate of $1.03 billion.

What price target have analysts set for MASI?

7 equities research analysts have issued twelve-month price targets for Masimo's shares. Their forecasts range from $134.50 to $207.00. On average, they anticipate Masimo's share price to reach $181.64 in the next twelve months. This suggests a possible upside of 3.0% from the stock's current price. View analysts' price targets for Masimo.

Has Masimo been receiving favorable news coverage?

Media headlines about MASI stock have been trending very negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Masimo earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned news articles about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near future. View the latest news aboutMasimo.

Are investors shorting Masimo?

Masimo saw a increase in short interest in March. As of March 13th, there was short interest totaling 1,237,200 shares, an increase of 29.9% from the February 27th total of 952,300 shares. Based on an average daily volume of 552,600 shares, the short-interest ratio is presently 2.2 days. Approximately 2.5% of the shares of the stock are short sold. View Masimo's Current Options Chain.

Who are some of Masimo's key competitors?

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Mastercard (MA), Twilio (TWLO), Intuitive Surgical (ISRG), Paypal (PYPL), Visa (V) and Shopify (SHOP).

Who are Masimo's key executives?

Masimo's management team includes the following people:
  • Mr. Joseph E. Kiani, Founder, CEO & Chairman (Age 54)
  • Mr. Micah Young, Exec. VP of Fin. & CFO (Age 40)
  • Mr. Anand Sampath, Chief Operating Officer (Age 53)
  • Dr. Steven J. Barker, Chairman of Scientific Advisory Board, Chief Science Officer & Director (Age 74)
  • Mr. Thomas Samuel McClenahan, Exec. VP, Gen. Counsel & Corp. Sec. (Age 46)

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

How do I buy shares of Masimo?

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $176.27.

How big of a company is Masimo?

Masimo has a market capitalization of $9.40 billion and generates $937.84 million in revenue each year. The medical equipment provider earns $196.22 million in net income (profit) each year or $3.22 on an earnings per share basis. Masimo employs 1,600 workers across the globe. View additional information about Masimo.

What is Masimo's official website?

The official website for Masimo is http://www.masimo.com/.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at 949-297-7000 or via email at [email protected]


MarketBeat Community Rating for Masimo (NASDAQ MASI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  399 (Vote Outperform)
Underperform Votes:  394 (Vote Underperform)
Total Votes:  793
MarketBeat's community ratings are surveys of what our community members think about Masimo and other stocks. Vote "Outperform" if you believe MASI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MASI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel